Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia-Reference-Cited by-同舟云学术

Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia

Published:2004-12-15 Issue:24 Volume:64 Page:8816-8820
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Bentires-Alj Mohamed,Paez J. Guillermo,David Frank S.,Keilhack Heike,Halmos Balazs,Naoki Katsuhiko,Maris John M.,Richardson Andrea,Bardelli Alberto,Sugarbaker David J.,Richards William G.,Du Jinyan,Girard Luc,Minna John D.,Loh Mignon L.,Fisher David E.,Velculescu Victor E.,Vogelstein Bert,Meyerson Matthew,Sellers William R.,Neel Benjamin G.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 455 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display KRAS and Extensive PTPN11/SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib;Genes;2024-08-09

2. Discovery of TK-642 as a highly potent, selective, orally bioavailable pyrazolopyrazine-based allosteric SHP2 inhibitor;Acta Pharmaceutica Sinica B;2024-08

3. Enzyme Is the Name—Adapter Is the Game;Cells;2024-07-25

4. Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation;The Journal of Pathology;2024-07-25

5. The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain;Proceedings of the National Academy of Sciences;2024-07-16